|
|
University of British Columbia
|
9
|
|
|
Aspreva Pharmaceuticals Corp
|
8
|
|
|
Canadian Genetic Diseases Network
|
5
|
|
|
Xenon Genetics
|
5
|
|
|
Neurovir Inc
|
5
|
|
|
University of Cape Town
|
3
|
|
|
Aspreva International Ltd (alternat name Aspreva Pharmaceuticals Corp)
|
3
|
|
|
CytRx Corp
|
2
|
|
|
Royal College of Physicians
|
2
|
|
|
Chromos Molecular Systems Inc
|
2
|
|
|
Zone
|
1
|
|
|
Royal Society
|
1
|
|
|
American Society of Clinical Investigation
|
1
|
|
|
Calyx Bio Ventures Inc
|
1
|
|
|
British Columbia
|
1
|
|
|
Amsterdam Molecular Therapeutics
|
1
|
|
|
Harvard Medical School
|
1
|
|
|
Amsterdam Molecular Therapeutics (AMT) Holding NV
|
1
|
|
|
Michael Smith Foundation for Health Research
|
1
|
|
|
Vancouver Sun
|
1
|
|
|
Med Biogene Inc
|
1
|